Prefer a chat interface with context about you and your work?
A Survival Mediation Model with Bayesian Model Averaging
Determining the extent to which a patient is benefiting from cancer therapy is challenging. Criteria for quantifying the extent of "tumor response" observed within a few cycles of treatment have been established for various types of solid as well as hematologic malignancies. These measures comprise the primary endpoints of phase …